Rebecca Cole1, Dhandapani Ashok2, Abdul Razack3, Amer Azaz2, Shaji Sebastian4. 1. Hull & York Medical School, Hull, United Kingdom. 2. Department of Paediatric Gastroenterology, Hull & East Yorkshire NHS Trust, Hull, United Kingdom. 3. Department of Radiology, Hull & East Yorkshire NHS Trust, Hull, United Kingdom. 4. Inflammatory Bowel Disease Unit, Hull & East Yorkshire NHS Trust, Hull, United Kingdom. Electronic address: shaji.sebastian@hey.nhs.uk.
Abstract
PURPOSE: We aimed to evaluate the impact of a transition service on clinical and developmental outcomes in adolescent Inflammatory Bowel Disease (IBD) patients on transfer to adult health care services. METHODS: We reviewed the records of IBD patients diagnosed in pediatric care following their transfer/attendance to the adult IBD service. The data on patients who attended the transition service were compared with those who did not pass through the transition service. RESULTS: Seventy-two patients were included in the study 41M and 31F. Forty-four patients went through the transition system (Group A), and 28 had no formalized transition arrangement before transfer (Group B). A significantly higher number of Group B patients needed surgery within 2 years of transfer when compared with patients in Group A (46% vs. 25%, p = .01). Sixty-one percent of patients in Group B needed at least one admission within 2 years of transfer when compared with 29% of Group A patients (p = .002). Nonattendance at clinics was higher in Group B patients with 78% having at least one nonattendance, whereas 29% of Group A failed to attend at least one appointment (p = .001). In addition, drug compliance rates were higher in the transition group when compared with Group B (89% and 46%, respectively; p = .002). A higher proportion of transitioned patients achieved their estimated maximum growth potential when completing adolescence. There was a trend toward higher dependence on opiates and smoking in Group B patients. CONCLUSIONS: In adolescent IBD patients, transition care is associated with better disease specific and developmental outcomes. Prospective studies of different models of transition care in IBD are needed.
PURPOSE: We aimed to evaluate the impact of a transition service on clinical and developmental outcomes in adolescent Inflammatory Bowel Disease (IBD) patients on transfer to adult health care services. METHODS: We reviewed the records of IBDpatients diagnosed in pediatric care following their transfer/attendance to the adult IBD service. The data on patients who attended the transition service were compared with those who did not pass through the transition service. RESULTS: Seventy-two patients were included in the study 41M and 31F. Forty-four patients went through the transition system (Group A), and 28 had no formalized transition arrangement before transfer (Group B). A significantly higher number of Group B patients needed surgery within 2 years of transfer when compared with patients in Group A (46% vs. 25%, p = .01). Sixty-one percent of patients in Group B needed at least one admission within 2 years of transfer when compared with 29% of Group A patients (p = .002). Nonattendance at clinics was higher in Group B patients with 78% having at least one nonattendance, whereas 29% of Group A failed to attend at least one appointment (p = .001). In addition, drug compliance rates were higher in the transition group when compared with Group B (89% and 46%, respectively; p = .002). A higher proportion of transitioned patients achieved their estimated maximum growth potential when completing adolescence. There was a trend toward higher dependence on opiates and smoking in Group B patients. CONCLUSIONS: In adolescent IBDpatients, transition care is associated with better disease specific and developmental outcomes. Prospective studies of different models of transition care in IBD are needed.
Authors: G Pellino; D S Keller; G M Sampietro; V Annese; M Carvello; V Celentano; C Coco; F Colombo; N Cracco; F Di Candido; M Franceschi; S Laureti; G Mattioli; L Pio; G Sciaudone; G Sica; V Villanacci; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi Journal: Tech Coloproctol Date: 2020-01-25 Impact factor: 3.781
Authors: Katherine J Baxter; Jahnavi K Srinivasan; Thomas R Ziegler; Tanvi Dhere; Richard R Ricketts; Megan M Durham Journal: Pediatr Surg Int Date: 2017-04-04 Impact factor: 1.827
Authors: Dava Szalda; Lisa Piece; Lauren Brumley; Yimei Li; Marilyn M Schapira; Monika Wasik; Wendy L Hobbie; Jill P Ginsberg; Lisa A Schwartz Journal: J Adolesc Health Date: 2016-10-27 Impact factor: 5.012
Authors: Lisette van Alewijk; Kirsten Davidse; Karlijn Pellikaan; Judith van Eck; Anita C S Hokken-Koelega; Theo C J Sas; Sabine Hannema; Aart J van der Lely; Laura C G de Graaff Journal: Endocr Connect Date: 2021-04-22 Impact factor: 3.335
Authors: Jane N T Sattoe; Mariëlle A C Peeters; Sander R Hilberink; Erwin Ista; AnneLoes van Staa Journal: BMJ Open Date: 2016-08-26 Impact factor: 2.692